POTASSIUM CITRATE

Product NDC: 42543-408
11-digit product format: 425430408
Labeler code: 42543
Product ID: 42543-408_e9e76355-cc27-427b-a787-7628a4b88eb7
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: POTASSIUM CITRATE
Dosage form: TABLET
Route: ORAL
Labeler: Strides Pharma Inc.
Application: ANDA206813
Marketing category: ANDA
Marketing start: 2017-11-01
Substance: POTASSIUM CITRATE
Active strength: 15 meq/1
Pharmacologic classes: Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE]
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A206813-001	POTASSIUM CITRATE	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11
A206813-002	POTASSIUM CITRATE	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11
A206813-003	POTASSIUM CITRATE	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A206813-001	AB
A206813-002	AB
A206813-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206813-002	POTASSIUM CITRATE	10MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206813-003	POTASSIUM CITRATE	15MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206813-001	POTASSIUM CITRATE	5MEQ	TABLET, EXTENDED RELEASE / ORAL	AB	2017-09-11	`1e350fbaab3a…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 126 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A206813-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206813-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A206813-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A206813-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206813-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A206813-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206813-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206813-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A206813-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A206813-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206813-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A206813-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206813-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206813-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A206813-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206813-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206813-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A206813-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206813-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206813-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A206813-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206813-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206813-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A206813-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206813-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206813-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A206813-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206813-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206813-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A206813-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A206813-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206813-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A206813-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206813-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206813-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A206813-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206813-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206813-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A206813-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A206813-001	AB	1	`1e350fbaab3a…`

Additional Listing Data#

Finished product: Yes
Brand name base: POTASSIUM CITRATE
Brand name suffix: EXTENDED RELEASE
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
POTASSIUM CITRATE	15 meq/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
EE90ONI6FF	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
199376	Internal RxNorm lookup
199381	Internal RxNorm lookup
898490	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
5f38b02c-703c-4fc2-b833-654e41bd617f	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906	Product name	7	20210625

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
42543-408-01	POTASSIUM CITRATEEXTENDED RELEASE	100 in 1 BOTTLE	TABLET	100		10

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
42543-408-01	EA - Each	42543-408	8b535d7b-f913-4baa-b914-893058893a25	1	2017-10-13

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
42543-408	POTASSIUM CITRATE EXTENDED RELEASE (POTASSIUM CITRATE) TABLET [STRIDES PHARMA INC.]	9	Current NDC, Legacy NDC, 1 package rows	20230622_5f38b02c-703c-4fc2-b833-654e41bd617f.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
POTASSIUM CITRATE EXTENDED RELEASE	POTASSIUM CITRATE	Bryant Ranch Prepack	3dd9c9eb-df19-4ec9-bc77-f3a159b33d94	2025-10-23	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206813 application number: ANDA206813
POTASSIUM CITRATE EXTENDED RELEASE	POTASSIUM CITRATE	Bryant Ranch Prepack	44ab2c4f-4a76-470d-98fb-8874c692a967	2025-08-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206813 application number: ANDA206813
POTASSIUM CITRATE EXTENDED RELEASE	POTASSIUM CITRATE	Strides Pharma Inc.	5f38b02c-703c-4fc2-b833-654e41bd617f	2025-07-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206813 application number: ANDA206813 ndc (product): 42543-408
POTASSIUM CITRATE EXTENDED RELEASE	POTASSIUM CITRATE	Bryant Ranch Prepack	8f5f7078-3c2d-406f-9222-b82a0f79d168	2025-05-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206813 application number: ANDA206813
POTASSIUM CITRATE EXTENDED RELEASE	POTASSIUM CITRATE	Bryant Ranch Prepack	b6ce81aa-ed9e-4eac-9f9c-26e2560f06db	2025-05-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206813 application number: ANDA206813
POTASSIUM CITRATE EXTENDED RELEASE	POTASSIUM CITRATE	Bryant Ranch Prepack	9774b7c5-4695-47c9-9eb8-e0af2e05f5c3	2024-05-20	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 206813 application number: ANDA206813

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
EE90ONI6FF	POTASSIUM CITRATE	6100-05-6	POTASSIUM CITRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
898490	potassium citrate 15 MEQ Extended Release Oral Tablet	PSN	8f5f7078-3c2d-406f-9222-b82a0f79d168	102
898490	potassium citrate 15 MEQ Extended Release Oral Tablet	SCD	8f5f7078-3c2d-406f-9222-b82a0f79d168	102
898490	K+ citrate 15 MEQ Extended Release Oral Tablet	SY	8f5f7078-3c2d-406f-9222-b82a0f79d168	102
898490	Pot citrate 15 MEQ Extended Release Oral Tablet	SY	8f5f7078-3c2d-406f-9222-b82a0f79d168	102
898490	potassium citrate 1620 MG Extended Release Oral Tablet	SY	8f5f7078-3c2d-406f-9222-b82a0f79d168	102
199381	potassium citrate 10 MEQ Extended Release Oral Tablet	PSN	5f38b02c-703c-4fc2-b833-654e41bd617f	10
898490	potassium citrate 15 MEQ Extended Release Oral Tablet	PSN	5f38b02c-703c-4fc2-b833-654e41bd617f	10
199376	potassium citrate 5 MEQ Extended Release Oral Tablet	PSN	5f38b02c-703c-4fc2-b833-654e41bd617f	10
199381	potassium citrate 10 MEQ Extended Release Oral Tablet	SCD	5f38b02c-703c-4fc2-b833-654e41bd617f	10
898490	potassium citrate 15 MEQ Extended Release Oral Tablet	SCD	5f38b02c-703c-4fc2-b833-654e41bd617f	10
199376	potassium citrate 5 MEQ Extended Release Oral Tablet	SCD	5f38b02c-703c-4fc2-b833-654e41bd617f	10
199381	K+ citrate 10 MEQ Extended Release Oral Tablet	SY	5f38b02c-703c-4fc2-b833-654e41bd617f	10
898490	K+ citrate 15 MEQ Extended Release Oral Tablet	SY	5f38b02c-703c-4fc2-b833-654e41bd617f	10
199376	K+ citrate 5 MEQ Extended Release Oral Tablet	SY	5f38b02c-703c-4fc2-b833-654e41bd617f	10
199381	Pot citrate 10 MEQ Extended Release Oral Tablet	SY	5f38b02c-703c-4fc2-b833-654e41bd617f	10
898490	Pot citrate 15 MEQ Extended Release Oral Tablet	SY	5f38b02c-703c-4fc2-b833-654e41bd617f	10
199376	Pot citrate 5 MEQ Extended Release Oral Tablet	SY	5f38b02c-703c-4fc2-b833-654e41bd617f	10
199381	potassium citrate 1080 MG Extended Release Oral Tablet	SY	5f38b02c-703c-4fc2-b833-654e41bd617f	10
898490	potassium citrate 1620 MG Extended Release Oral Tablet	SY	5f38b02c-703c-4fc2-b833-654e41bd617f	10
199376	potassium citrate 540 MG Extended Release Oral Tablet	SY	5f38b02c-703c-4fc2-b833-654e41bd617f	10

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
42543-408-01	42543040801	100 TABLET in 1 BOTTLE (42543-408-01)	100 tablet	2017-11-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
POTASSIUM CITRATE EXTENDED RELEASE	Strides Pharma Inc. \| Strides Pharma Science Limited	2025-07-01	HUMAN PRESCRIPTION DRUG LABEL	10
POTASSIUM CITRATE EXTENDED RELEASE	Bryant Ranch Prepack	2025-05-02	HUMAN PRESCRIPTION DRUG LABEL	102